Men's behaviour towards prostate cancer screening

Postgraduate Medical Journal

Volumn 84, Issue 988, 2008, Pages 57-59

  Papatsoris, Athanasios G ^a   Anagnostopoulos, Fotios ^b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b PANTEION UNIVERSITY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ATTITUDE TO ILLNESS; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; DIGITAL RECTAL EXAMINATION; EARLY DIAGNOSIS; EDITORIAL; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HIGH RISK POPULATION; HUMAN; PATIENT DECISION MAKING; PATIENT EDUCATION; PROSTATE CANCER; QUALITY OF LIFE; REFUSAL TO PARTICIPATE; SPOUSE;

ATTITUDE TO HEALTH; HEALTH BEHAVIOR; HEALTH PERSONNEL; HUMANS; INTERPERSONAL RELATIONS; MALE; MASS SCREENING; PATIENT EDUCATION AS TOPIC; PROFESSIONAL ROLE; PROFESSIONAL-PATIENT RELATIONS; PROSTATIC NEOPLASMS; SPOUSES;

EID: 41149107392     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2007.064162     Document Type: Editorial

References (17)

1. Papatsoris AG, Karamouzis MV, Papavassiliou AG. Novel biological agents for the treatment of hormone-refractory prostate cancer (HRPC). Curr Med Chem 2005;12:277-96.
2. Dawson C, Whitfield H. ABC of urology. Urological malignancy - 1: prostate cancer. BMJ 1996;312:1032-4.
3. Chrisofos M, Papatsoris AG, Dellis A, et al. Can prostate biopsies affect erectile function? Andrologia 2006;38:79-83.
4. National Health Service. Prostate cancer risk management. http://www.cancerscreening.nhs.uk/prostate.
5. US Department of Health and Human Services, Agency for Healthcare Research and Quality. Screening for prostate cancer. http://www.ahrg.gov/clinic/uspstf/uspsprca.htm.
6. Bryant RJ, Hamdy FC. Screening for prostate cancer: an update. Eur Urol 2007 Aug 27; [Epub ahead of print].
7. Nijs HG, Essink-Bot ML, DeKoning HJ, et al. Why do men refuse or attend population-based screening for prostate cancer? J Public Health Med 2000;22:312-6.
8. Guerra CE, Jacobs SE, Holmes JH, et al. Are physicians discussing prostate cancer screening with their patients and why or why not? A pilot study. J Gen Intern Med 2007;22:901-7.
9. Myers RE, Hyslop T, Jennings-Dozier K, et al. Intention to be tested for prostate cancer risk among African-American men. Cancer Epidemiol Biomarkers Prev 2000;9:1323-8.
10. Volk RJ, Cantor SB, Cass AR, et al. Preferences of husbands and wives for outcomes of prostate cancer screening and treatment. J Gen Intern Med 2004;19:339-48.
11. Gray RE, Philbrook A. Whose prostate is it anyway? CMAJ 1999;160:833-6.
12. McFall SL. US men discussing prostate-specific antigen tests with a physician. Ann Fam Med 2006;4:433-6.
13. Clements A, Watson E, Rai T, et al. The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a gualitative study. BMC Fam Pract 2007;8:35.
14. Evans R, Edwards AG, Elwyn G, et al. "It's a maybe test": men's experiences of prostate specific antigen testing in primary care. Br J Gen Pract 2007;57:303-10.
15. Chan EC, Vernon SW, O'Donnell F, et al. Informed consent for cancer screening with prostate-specific antigen: how well are men getting the message? Am J Public Health 2003;93:779
16. Frosch DL, Kaplan RM, Felitti VJ. A randomized controlled trial comparing internet and video to facilitate patient education for men considering the prostate specific antigen test. J Gen Intern Med 2003;18:781-7.
17. Partin MR, Nelson D, Radosevich D, et al. Randomized trial examining the effect of two prostate cancer screening educational interventions on patient knowledge, preferences, and behaviors. J Gen Intern Med 2004;19:835-42.